Company: NCEL
Filing Date: 2025-09-10
Form Type: 424B3
Source: 0001213900-25-086600
Chunk: 437

Company: NewcelX Ltd.
Filing Date: 2025-09-10
Form: 424B3
Chunk 437
---
 rate of 10% per annum and mature on the earlier of June30, 2024 or a liquidity event with a strategic partner. On March18, 2024, we entered into an addendum to the Short Term Loan Agreement with the Short Term Lender, and a series of addendums to the Bridge Loan Agreements with the Bridge Lenders, each providing for an extension of the maturity date under the Loan Agreements to December31, 2024. On May13, 2024, we entered into the second short term addendum, or the Second Short Term Addendum, to the Short Term Loan Agreement dated September28, 2023, and a short term addendum, or the Short Term Addendum, to the Short Term Loan Agreement dated November15, 2023, with the Short Term Lender providing for an extension of the maturity date under the Short Term Loan Agreements to June30, 2025. On October10, 2024, the Company successfully implemented a restructuring measure by converting the claims of debt holders. On March 20, 2024, we entered into a securities purchase agreement, or the March Purchase Agreement, providing for the issuance in a registered direct offering of 7,000,000 NLS Common Shares, at a purchase price of $0.25 per share. The offering closed on March22, 2024. In addition, pursuant to the March Purchase Agreement, the investors received unregistered warrants, or the Common Warrants, to purchase up to an aggregate of 3,500,000 NLS Common Shares at an exercise of $0.25 per share in a concurrent private placement. The Common Warrants were immediately exercisable upon issuance and will expire five years following the date of issuance. The March Purchase Agreement contains customary representations and warranties and agreements of the Company and the investors and customary indemnification rights and obligations of the parties. Pursuant to the March Purchase Agreement, we agreed not to enter into any agreement to issue or announce the issuance or proposed issuance of any NLS Common Shares or NLS Common Share equivalents for a period of 45 days following the closing of the offering, subject to certain customary exceptions. We have also agreed that from the date of the March Purchase Agreement until one year after the closing date of the offering, we shall not enter into an agreement to effect any issuance by us or any of our subsidiaries of NLS Common Shares or NLS Common Share equivalents (or a combination of units thereof) involving a variable rate transaction.